Publication | Closed Access
A multicenter trial of cytarabine plus idarubicin or daunorubicin as induction therapy for adult nonlymphocytic leukemia.
40
Citations
0
References
1989
Year
Hematological MalignancyOncologyInduction TherapyMedicineHematologyPharmacotherapyMulticenter TrialPharmacologyAdult Nonlymphocytic LeukemiaCancer ResearchMyeloid Neoplasia
No additional data available for this publication yet. Check back later!